KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non Operating Income (2016 - 2025)

Sarepta Therapeutics has reported Other Non Operating Income over the past 15 years, most recently at -$121.7 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$121.7 million for Q4 2025, down 1309.88% from a year ago — trailing twelve months through Dec 2025 was -$28.2 million (down 166.07% YoY), and the annual figure for FY2025 was $16.9 million, down 60.5%.
  • Other Non Operating Income for Q4 2025 was -$121.7 million at Sarepta Therapeutics, down from $138.6 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for SRPT hit a ceiling of $387.3 million in Q1 2023 and a floor of -$121.7 million in Q4 2025.
  • Median Other Non Operating Income over the past 5 years was $6.5 million (2024), compared with a mean of $33.7 million.
  • Biggest five-year swings in Other Non Operating Income: surged 31469.43% in 2022 and later tumbled 1370.55% in 2025.
  • Sarepta Therapeutics' Other Non Operating Income stood at $656000.0 in 2021, then soared by 742.53% to $5.5 million in 2022, then soared by 6907.42% to $387.3 million in 2023, then tumbled by 97.4% to $10.1 million in 2024, then crashed by 1309.88% to -$121.7 million in 2025.
  • The last three reported values for Other Non Operating Income were -$121.7 million (Q4 2025), $138.6 million (Q3 2025), and $38.1 million (Q2 2025) per Business Quant data.